Why the IMEXHS (ASX:IME) share price soared 6% higher today

The IMEXHS Ltd (ASX: IME) share price soared higher today following a positive sales update for the company's Aquila in the Cloud product.

hand on touch screen lit up by a share price chart moving higher

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IMEXHS Ltd (ASX: IME) share price soared today following a positive sales update for its Aquila in the Cloud product.

At the time of writing, the company is trading 6.94% higher at $1.85 per share.

What did IMEXHS announce?

The IMEXHS share price is outperforming the All Ordinaries Index (ASX: XAO) today.

According to its release, IMEXHS advised that its standardised radiology solution, Aquila in the Cloud, has ended the year on a strong note.

For the period ending 31 December 2020, the company's product saw a total of 41 contracts signed. This is expected to translate to more than $945,000 in annual recurring revenue (ARR) for the company.

Launched last May, Aquila in the Cloud is an affordable and accessible product that improves patient outcomes in imaging diagnosis and treatment.

Hosted within Microsoft Azure, healthcare providers pay a connection and establishment fee for the software service. This allows access to the advanced imaging tools on a fee per study basis, helping to reduce overall costs.

IMEXHS customers include small-to medium-sized customers across 11 markets including the United States, Mexico, Central America, and Columbia.

Management commentary

IMEXHS co-founder and CEO Dr German Arango commented on the result:

The strong demand we are experiencing in multiple markets for Aquila in the Cloud reflects the gap which exists for a low-cost radiology solution that meets the needs of small to mid-size operators. Our affordable product offering provides us with a unique opportunity to democratise access to medical imaging which is currently not available to around two-thirds of the world's population. At IMEXHS, we firmly believe that Aquila in the Cloud represents an important step forward to improving the health outcomes of communities across the globe.

About the IMEXHS share price

The IMEXHS share price has been on a rollercoaster ride over the past 12 months. The company's shares reached a high of $2.55 last January, before falling to a multi-year low of 75 cents in March.

Based on the current IMEXHS share price, the company commands a market capitalisation of around $51 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A player pounces on the ball in the scoring zone of the field.
Best Shares

4 ASX 300 shares that ripped 100% or more in 2025

The S&P/ASX 300 Index rose 7.17% and delivered a total return, including dividends, of 10.66% in 2025.

Read more »

A little girl is about to launch down the slide with a blue sky and white clouds in the sky behind her.
Broker Notes

BHP vs. Fortescue shares: Goldman Sachs says 1 will rip and 1 will dip

Top broker Goldman Sachs upgraded its 12-month share price forecasts for BHP and Fortescue shares this week.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Brokers rate these 3 ASX shares as buys in January

These ASX shares have an exciting outlook according to experts.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Australian Ethical, Northern Minerals, PLS, and Woodside shares are falling today

These shares are ending the week in the red. But why?

Read more »